01 Pages : 1-17
http://dx.doi.org/10.31703/gpsr.2023(VIII-III).01 10.31703/gpsr.2023(VIII-III).01 Published : Sep 2023An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan
To determine the frequency of iron deficiency anemia (IDA) in children who present with clinical pallor The study was conducted at a tertiary care hospital, Hayatabad Medical Complex, between August 2018 and July 2022. We utilized laboratory information and took blood samples of 5ml to check for hemoglobin and ferritin levels. The criteria for IDA diagnosis were the presence of low hemoglobin levels (<11gm/dl) and low ferritin levels (<30ng/ml). The data were analyzed using SPSS version 26. The study contained 492 children between the ages of 1 year to 15 years. The total number of anemic was 467 (94.9%) and Iron Deficiency Anemia was found to be present in 28.8% of the patients. Our study concludes that the frequency of iron deficiency is high in children presenting with pallor. Initiatives like National programs incorporating short-term measures like iron supplements and long-term ones like fortifying wheat flour could decrease the burden of IDA.
-
ron Deficiency Anemia, Pallor, Children, Prevalence
-
(1) Anam Arshad
PhD Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(2) Rimsha Abaidullah
PhD Scholar, Department of Zoology, Government College University, Lahore, Punjab, Pakistan.
(3) Maria Naz Bakhtiari
PhD Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(4) Dur E Nayab
PhD Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
(5) Muhammad Zahoor
PhD Scholar, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
-
Walker, R., & Whittlesea, C. (2007c). Clinical pharmacy and Therapeutics.
Programme, G. T. (2011, January 1). Global tuberculosis control: WHO report 2011. https://www.who.int/publications/i/item/9789241564380
- American Lung Association. Tuberculosis. Symptoms, diagnosis, and treatment. www.lung.org/lung-disease/tuberculosis/symptoms-diagnosis.html. Accessed February 9, 2012.
- Tavitian, S. M., Spalek, V. H., & Bailey, R. P. (2003). A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers. American Journal of Health-system Pharmacy, 60(18), 1856–1861. https://doi.org/10.1093/ajhp/60.18.1856
-
Troy, D. B., & Beringer, P. (2006). Remington: The Science and Practice of Pharmacy. Lippincott Williams & Wilkins.Dye, C. (2006). Global epidemiology of tuberculosis. The Lancet, 367(9514), 938-940.
- Programme, G. T. (2011b, January 1). Global tuberculosis control: WHO report 2011. https://www.who.int/publications/i/item/9789241564380
-
Tuberculosis in Pakistan: Are we losing the battle? By Abdul Basitwww.jpma.org.pk/full_article_text.php?article_id=234
- Fitzgerald, D., Sterling, T., & Haas, D. (2015). 251 – Mycobacterium tuberculosis. https://www.semanticscholar.org/paper/251-%E2%80%93-Mycobacterium-tuberculosis-Fitzgerald-Sterling/e3be283e00e375dd678decdcacf7248f6f8af52e
- GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7th ed. Philapedia, PA: Churchill Livingstone Elsevier; 2010: 3129-3164
- GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7th ed. Philapedia, PA: Churchill Livingstone Elsevier; 2010: 3129-3164
- Corbett EL, Marston B, Churchyard CJ, CDC. Tuberculosis. Basic TB facts. Risk of transmission www.cdc.gov/tb/topic/basics/risk.htm. Accessed March 9, 2012.
- Mazurek, G. H., Jereb, J. A., Vernon, A., Lobue, P. A., Goldberg, S., & Castro, K. G. (2010). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. PubMed, 59(RR-5), 1–25. https://pubmed.ncbi.nlm.nih.gov/20577159
- Ena, J., & Valls, V. (2005). Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis. Clinical Infectious Diseases/Clinical Infectious Diseases (Online. University of Chicago. Press), 40(5), 670–676. https://doi.org/10.1086/427802
- Jereb, J. A., Goldberg, S., Powell, K. M., Villarino, M. E., & LoBue, P. (2011). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. Recommendations for Use of an Isoniazid-Rifapentine Regimen With Direct Observation to Treat Latent Mycobacterium Tuberculosis Infection. https://stacks.cdc.gov/view/cdc/20846
- Horne, R., Barber, N., Weinman, J., Ra, E., Morgan, M., & Cribb, A. (2006). NHS service delivery and organisation R&D programme: concordance, adherence and compliance in medicine taking. Concordance, Adherence and Compliance in Medicine Taking. https://www.research.manchester.ac.uk/portal/en/publications/nhs-service-delivery-and-organisation-rd-programme-concordance-adherence-and-compliance-in-medicine-taking(5ed745f3-a769-47bd-a54b-09f1c8768e8a)/export.html
- Cramer, J. A., Roy, A., Burrell, A., Fairchild, C., Fuldeore, M., Ollendorf, D. A., & Wong, P. (2008). Medication Compliance and Persistence: Terminology and Definitions. Value in Health, 11(1), 44–47. https://doi.org/10.1111/j.1524-4733.2007.00213.x
- Cuneo, W. D., & Snider, D. E. (1989). Enhancing Patient Compliance with Tuberculosis Therapy. Clinics in Chest Medicine, 10(3), 375–380. https://doi.org/10.1016/s0272-5231(21)00640-7
- WHO (2006). An expanded DOTS framework for effective tuberculosis control. (2002). PubMed, 6(5), 378–388. https://pubmed.ncbi.nlm.nih.gov/12019913
- Last, J. M., & Kozakiewicz, J. (2009). Development of a pharmacist-managed latent tuberculosis clinic. American Journal of Health-system Pharmacy, 66(17), 1522–1523. https://doi.org/10.2146/ajhp090034
- Clark, P. M., Karagöz, T., Apikoğlu-Rabuş, Ş., & İzzettin, F. (2007). Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-system Pharmacy, 64(5), 497–505. https://doi.org/10.2146/ajhp050543
-
(MMWR, 2003). Update: Adverse event data and Revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of Latent Tuberculosis Infection---United States, 2003. (2003, August 8). https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm
Cite this article
-
APA : Arshad, A., Abaidullah, R., & Bakhtiari, M. N. (2023). An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan. Global Pharmaceutical Sciences Review, VIII(III), 1-17. https://doi.org/10.31703/gpsr.2023(VIII-III).01
-
CHICAGO : Arshad, Anam, Rimsha Abaidullah, and Maria Naz Bakhtiari. 2023. "An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan." Global Pharmaceutical Sciences Review, VIII (III): 1-17 doi: 10.31703/gpsr.2023(VIII-III).01
-
HARVARD : ARSHAD, A., ABAIDULLAH, R. & BAKHTIARI, M. N. 2023. An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan. Global Pharmaceutical Sciences Review, VIII, 1-17.
-
MHRA : Arshad, Anam, Rimsha Abaidullah, and Maria Naz Bakhtiari. 2023. "An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan." Global Pharmaceutical Sciences Review, VIII: 1-17
-
MLA : Arshad, Anam, Rimsha Abaidullah, and Maria Naz Bakhtiari. "An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan." Global Pharmaceutical Sciences Review, VIII.III (2023): 1-17 Print.
-
OXFORD : Arshad, Anam, Abaidullah, Rimsha, and Bakhtiari, Maria Naz (2023), "An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan", Global Pharmaceutical Sciences Review, VIII (III), 1-17
-
TURABIAN : Arshad, Anam, Rimsha Abaidullah, and Maria Naz Bakhtiari. "An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan." Global Pharmaceutical Sciences Review VIII, no. III (2023): 1-17. https://doi.org/10.31703/gpsr.2023(VIII-III).01